Applications from the field of Pharma & Biopharma focused on LC/MS/MS - page 8
Open paper Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
LC/MS, LC/MS/MS, LC/QQQ, Software
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ, Software
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
Development of timsMRMS: A Gated-TIMS FT-ICR MS instrument to decipher isomeric content of complex organic mixtures
LC/MS, LC/MS/MS, Ion Mobility, LC/Ultra-HRMS, MALDI, MS Imaging
Instrumentation
LC/MS, LC/MS/MS, Ion Mobility, LC/Ultra-HRMS, MALDI, MS Imaging
Manufacturer
Bruker
Industries
Pharma & Biopharma
Open paper Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
Higher Throughput Intact Mass Confirmation and Impurity Screening of GLP-1 Analogues Using Multi-Reflecting TOF Technology and INTACT Mass 1.9 Application
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Consumables, LC columns, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
Consumables, LC columns, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Effect of column chemistry, temperature, inert flow path, and mobile phase on the separation of GLP-1 peptides and their impurities
Effect of column chemistry, temperature, inert flow path, and mobile phase on the separation of GLP-1 peptides and their impurities
LC/MS, LC/MS/MS, Consumables, LC columns, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, Consumables, LC columns, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
Integrated LC/UV and LC/MS Workflows for Impurity and Degradation Characterization of GLP-1 Agonists
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Consumables, LC columns
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, HPLC, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
